Scott Li, a Partner at CRG, shares his thoughts on recent deal flow and how CRG has been able to establish a track record of successfully investing in the healthcare industry for more than two decades.
In the September 2024 edition of Haynes Boone's "Private Credit Connections," Scott Li, a Partner at CRG, shares insights into the firm's healthcare investment strategies. Li discusses the robust deal flow in 2024, attributing it to CRG's extensive industry experience and a well-developed pipeline that allows for long-term tracking of potential investments. He emphasizes CRG's exclusive focus on healthcare, which enables the firm to source proprietary deals with minimal competition. Li also highlights the importance of understanding a company's growth trajectory, management team, and market segment to provide value beyond capital. An example of this approach is CRG's $50 million loan to OrthAlign, facilitated by a longstanding relationship with its CEO.
For a more in-depth understanding of CRG's investment philosophy and strategies, you can download the full interview here:
The U.S. is facing a worsening behavioral health crisis, highlighted by challenges exposed during the COVID-19 pandemic. In May 2023, U.S. Surgeon General Dr. Vivek Murthy described loneliness and isolation as a significant public health crisis, emphasizing the importance of human connection for healing and well-being.
CRG’s Brian Englander sat down with Joe Catanese, CEO of Calyxo, to discuss the kidney stone market, his career, and how his team is working to change kidney stone treatment through its innovative technology, ultimately improving the quality of care for patients who suffer from kidney stones.